Reduced tumour growth rates of GABPα KD PC cells were observed in a pre-clinical model (flank subcutaneous xenografts in immunodeficient mice) with tumours remaining sensitive to GABPα KD following surgical castration (Figure 4H). This evidence concerns the gene GABPA and neoplasm.